E6/E7 mRNA Expression of High-risk HPV Types in 849 Greek Women

被引:4
作者
Argyri, Elena [1 ]
Tsimplaki, Elpida [1 ]
Daskalopoulou, Dimitra [2 ]
Stravopodis, Dimitrios J. [4 ]
Kouikoglou, Ourania [1 ]
Terzakis, Emmanouil [3 ]
Panotopoulou, Efstathia [1 ]
机构
[1] St Savvas Reg Anticanc Oncol Hosp Athens, Dept Virol, Athens 11522, Greece
[2] St Savvas Reg Anticanc Oncol Hosp Athens, Dept Cytopathol, Athens 11522, Greece
[3] St Savvas Reg Anticanc Oncol Hosp Athens, Dept Gynaecol 2, Athens 11522, Greece
[4] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece
关键词
HPV; E6; E7; Greece; HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; PREVALENCE; E6; TRANSCRIPTS; WORLDWIDE; AGE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The goal of this study was to investigate human papillomavirus (HPV) geno typing and high-risk HPV E6/E7 mRNA expression in 849 women. Patients and Methods: 849 Cervical samples were obtained from patients attending an outpatient clinic to have their annual gynaecological check-up. All patients underwent a conventional Pap test. The patients were also offered HPV test with the knowledge that it is not part of the screening. Results: Overall prevalence of HPV DNA was 41.3%, while E6/E7 mRNA expression was found in 20.7% of the patients. HPV DNA and E6/E7 mRNA expression were detected in 21.1% and 9.1% of normal cytological samples, respectively, 38.1% and 23.8% of atypical squamous cells of unknown significance, 84.8% and 40.7% of low-grade squamous intraepithelial lesions, and 96.4% and 89.3% of high-grade squamous intraepithelial lesions, respectively. HPV 16 was the most frequent genotype identified. Conclusion: E6/E7mRNA detection might be useful as a screening marker for the early prediction of active infections and subsequent progression to severe dysplasia.
引用
收藏
页码:4007 / 4011
页数:5
相关论文
共 24 条
  • [1] Prevalence and distribution of high-risk human papillomavirus in Greece
    Agorastos, Theodoros
    Lambropoulos, Alexandros F.
    Sotiriadis, Alexandros
    Mikos, Themistoklis
    Togaridou, Eleonora
    Emmanouilides, Christos J.
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2009, 18 (06) : 504 - 509
  • [2] A cross sectional study of HPV type prevalence according to age and cytology
    Argyri, Elena
    Papaspyridakos, Stefanos
    Tsimplaki, Elpida
    Michala, Lina
    Myriokefalitaki, Evangelia
    Papassideri, Issidora
    Daskalopoulou, Dimitra
    Tsiaoussi, Ioanna
    Magiakos, George
    Panotopoulou, Efstathia
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [3] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [4] Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the Cervix
    Cattani, Paola
    Zannoni, Gian Franco
    Ricci, Caterina
    D'Onghia, Sara
    Trivellizzi, Ilaria Nausica
    Di Franco, Aldo
    Vellone, Valerio G.
    Durante, Maria
    Fadda, Giovanni
    Scambia, Giovanni
    Capelli, Giovanni
    De Vincenzo, Rosa
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (12) : 3895 - 3901
  • [5] RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus
    Cattani, Paola
    Siddu, Alessia
    D'Onghia, Sara
    Marchetti, Simona
    Santangelo, Rosaria
    Vellone, Valerio G.
    Zannoni, Gian Franco
    Fadda, Giovanni
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2136 - 2141
  • [6] Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
    Clifford, GM
    Smith, JS
    Plummer, M
    Muñoz, N
    Franceschi, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 63 - 73
  • [7] New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
    Doeberitz, MV
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (17) : 2229 - 2242
  • [8] Primary high-risk HPV screening for cervical cancer in post-menopausal women
    Gyllensten, Ulf
    Gustaysson, Inger
    Lindell, Monica
    Wilander, Erik
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 343 - 345
  • [9] PERSISTENT GENITAL HUMAN PAPILLOMAVIRUS INFECTION AS A RISK FACTOR FOR PERSISTENT CERVICAL DYSPLASIA
    HO, GYF
    BURK, RD
    KLEIN, S
    KADISH, AS
    CHANG, CJ
    PALAN, P
    BASU, J
    TACHEZY, R
    LEWIS, R
    ROMNEY, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18): : 1365 - 1371
  • [10] Molecular epidemiology of human papillomavirus
    Hoory, Talia
    Monie, Archana
    Gravitt, Patti
    Wu, T-C.
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (03) : 198 - 217